And if they make an announcement regarding the commericalization and release of their product to hospitals and medical offices, you are SCRUED my friend! I own over 50K shares and not selling one single share because I know there are companies like Illumina who are EXTREMELY interested in Trove. Any partnership of sort will skyrocket this stock. Then, people like you will disappear!
Upgrades are coming. We are at the top of the Analyst targets. Someone has got to wake up and move us up. I added yesterday and again today. We are reaching $15 short term and $20 very soon. And then, if we get a buyout, $25 to $30 is a sure price. Longer term, this could be as big as Ilumina.
This statement worries me a little. It does not show a lot of confidence..... I hope what they say is a bit more optimistic!
"Our product development and commercialization efforts are in their early stages, and we cannot make estimates of the costs or the time our development efforts will take to complete, or the timing and amount of revenues related to the sale of our tests and revenues related to our license agreements. The risk of completion of any program is high because of the many uncertainties involved in bringing new diagnostic products to market including the long duration of clinical testing, the specific performance of proposed products under stringent clinical trial protocols and/or CLIA requirements, the extended regulatory approval and review cycles, our ability to raise additional capital, the nature and timing of research and development expenses, and competing technologies being developed by organizations with significantly greater resources.